In a significant leap forward for oncology, the U.S. Food and Drug Administration (FDA) has given the green light to Astellas Pharma Inc.'s VYLOY (zolbetuximab-clzb) for treating adults with advanced, unresectable, or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric
Respiratory syncytial virus (RSV) has long been a formidable challenge, particularly for infants and older adults. Characterized by cold-like symptoms, RSV can sometimes escalate into severe respiratory conditions necessitating hospitalization. Nearly every child is exposed to RSV by the age of
Sutro Biopharma, Inc. (NASDAQ:STRO) has experienced a dramatic drop in its stock value over the last three years, significantly impacting its shareholders who have seen their investments diminish by 80%. Despite the company's impressive annual revenue growth of 38%, this financial success
The U.S. Food and Drug Administration (FDA) recently paused clinical trials for Novavax's combination COVID-19 and influenza vaccine, as well as its standalone flu vaccine. This unexpected halt was prompted by a serious adverse event involving motor neuropathy in a participant from the Phase 2
Tevogen Bio Holdings Inc. (Nasdaq: TVGN), along with its founding CEO, Dr. Ryan Saadi, has been honored for pioneering efforts in addressing health inequality through innovative medical solutions. The company, recognized by the Warren Township of New Jersey, received a proclamation from Mayor
The biopharmaceutical industry has been shaken by the European Union's recent ban on Triton X-100, a detergent essential for preventing viral contamination in biologics and plasma-derived products. Since its enactment in 2021, this regulatory change has catalyzed a worldwide search for
Big data analysis has emerged as an indispensable resource in the healthcare and life sciences sectors, with companies like PurpleLab leading the charge in leveraging data aggregation to assist pharmaceutical firms, healthcare providers, and payers in enhancing clinical, marketing, and operational
In a significant development for global health preparedness, RedHill Biopharma Ltd. has partnered with the Biomedical Advanced Research and Development Authority (BARDA) to advance opaganib, a promising treatment for Ebola virus disease (EBOV). This collaboration marks a crucial step in combating
The pharmaceutical packaging industry stands at the precipice of a significant transformation. With an anticipated growth from $110.55 billion in 2024 to $176.94 billion by 2032, driven by the increasing prevalence of biologics, stringent regulations, and the menace of drug counterfeiting, it is
In a dynamic twist within the pharmaceutical industry, several companies are locked in a fierce race to develop the next generation of obesity drugs. As the battle heats up, each aims to outdo the other, with innovations that promise to revolutionize the way obesity is treated. This race isn't
